Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 50%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is a company with a strategic focus on preferred payor relationships and specialized care for children, making it a promising investment opportunity with a strong track record and potential for growth. With the recent acquisition of Family First leading to a 50% increase in stock value, the company is targeting increased revenue and EBITDA. Risks include government reimbursement and nurse availability, but the company's commitment to compliance and diverse leadership team position it well for success in the value-based care model.

Bears say

Aveanna Healthcare Hldgs is facing significant risks due to its reliance on Medicaid reimbursement, which makes up the majority of its revenue and is subject to potential policy changes and rate updates. Its debt load is also a concern, despite its differentiated preferred payer strategy, and its operating environment remains mixed. However, the company has strong differentiators in its managed care mix, broad payor relationships, and specialized PDN platform, and is well-positioned to capitalize on the growing demand for home-based care. Its recent adjusted EBITDA guidance raise and positive outlook for the home care industry may support its outperform rating, but risks related to funding and recovery may hinder upside potential.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 50% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.